<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000686898"><TermName>zibotentan</TermName><TermPronunciation>(zy-boh-TEN-tan)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. Zibotentan may block cancer cell growth. It is a type of endothelin-A receptor antagonist.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000727613" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;zibotentan&quot;" language="en" id="_3"/><MediaLink ref="CDR0000727614" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;zibotentán&quot;" language="es" id="_4"/><SpanishTermName>zibotentán</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. El zibotentán podría impedir el crecimiento de las células. Es un tipo de antagonista del receptor de la endotelina A.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-11-24</DateFirstPublished></GlossaryTerm>
